Jeff Auxier's LLY Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 613 shares of Eli Lilly and Company (LLY) worth $467,719, representing 0.07% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Jeff Auxier has maintained a strategic position in LLY, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 10 shares. Largest reduction occurred in Q3 2024, reducing 42 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Jeff Auxier
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2021 | +726 | New Buy | 726 | $276.86 |
| Q3 2023 | +10 | Add 1.38% | 736 | $537.13 |
| Q4 2023 | -25 | Reduce 3.40% | 711 | $582.92 |
| Q1 2024 | -11 | Reduce 1.55% | 700 | $777.96 |
| Q2 2024 | -31 | Reduce 4.43% | 669 | $905.38 |
| Q3 2024 | -42 | Reduce 6.28% | 627 | $885.94 |
| Q1 2025 | -12 | Reduce 1.91% | 615 | $825.91 |
| Q2 2025 | -1 | Reduce 0.16% | 614 | $779.53 |
| Q3 2025 | -1 | Reduce 0.16% | 613 | $763.00 |
Jeff Auxier's Eli Lilly and Company Investment FAQs
Jeff Auxier first purchased Eli Lilly and Company (LLY) in Q4 2021, acquiring 726 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held Eli Lilly and Company (LLY) for 16 quarters since Q4 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier's largest addition to Eli Lilly and Company (LLY) was in Q4 2021, adding 726 shares worth $201,000. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 613 shares of Eli Lilly and Company (LLY), valued at approximately $467,719. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Eli Lilly and Company (LLY) represents approximately 0.07% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier's peak holding in Eli Lilly and Company (LLY) was 736 shares, as reported at the end of Q3 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.